FrancophonIA/ELRC3.0 huggingface dataset:
English: Oral anticoagulants: the concomitant administration of Clopidogrel with oral anticoagulants is not recommended since it may increase the intensity of bleedings (see section 4.4).
Danish: Orale antikoagulantia: Samtidig administration af Clopidogrel og orale antikoagulantia kan ikke anbefales, da det kan øge blødningstendensen (se pkt.
English: The concomitant administration of Clopidogrel with oral anticoagulants is not recommended since it may increase the intensity of bleedings (see section 4.5).
Danish: Samtidig administration af Clopidogrel og orale antikoagulantia kan ikke anbefales, da det kan øge blødningstendensen (se pkt.
English: At very high doses, a poor gastric tolerability (gastritis, gastric erosions and/or vomiting) of Clopidogrel was also reported in rat and baboon.
Danish: Ved meget høje doser Clopidogrel blev der hos rotter og bavianer observeret dårlig gastrisk tolerans (gastritis, gastriske erosioner og/eller opkastning).
English: Then, the usual dose is one 75 mg tablet of Clopidogrel 1A Pharma per day to be taken orally with or without food, and at the same time each day.
Danish: Derefter er den normale dosis 1 tablet Clopidogrel 1A Pharma à 75 mg daglig, som indtages gennem munden alene eller i forbindelse med et måltid.
English: No antidote to the pharmacological activity of Clopidogrel has been found.
Danish: Der er ikke fundet en aktiv farmakologisk antidot til Clopidogrel.
English: ST segment elevation acute myocardial infarction: Clopidogrel should be given as a single daily dose of 75 mg initiated with a 300 mg loading dose in combination with ASA and with or without thrombolytics.
Danish: - akut myokardieinfarkt med elevation af ST-segmentet: Behandling med Clopidogrel bør bestå af en daglig dosering på 75 mg, indledt med en stabiliseringsdosis på 300 mg i kombination med ASA og med eller uden trombolytika.
English: White (n=1356)
Danish: Kaukasisk (n=1.356)
English: In the intention to treat analysis, 939 events were observed in the Clopidogrel group and 1,020 events with ASA (relative risk reduction (RRR) 8.7%, [95% CI: 0.2 to 16.4]; p = 0.045), which corresponds, for every 1,000 patients treated for 2 years, to 10 [CI: 0 to 20] additional patients being prevented from experiencing a new ischaemic event.
Danish: I intention-to-treat-analysen blev der observeret 939 tilfælde i Clopidogrelgruppen og 1.020 tilfælde i ASA-gruppen (relativ risikoreduktion (RRR) 8,7 % [95 % CI: 0,2-16,4], p=0,045), hvilket for hver 1000 patienter, der blev behandlet i 2 år, svarer til, at yderligere 10 [CI: 0-20] patienter beskyttes mod et nyt iskæmisk tilfælde.
English: • You should tell your doctor if a surgery (including dental) is planned.
Danish: • Bør De fortælle Deres læge, at De er i behandling med Clopidogrel 1A Pharma hvis De skal have foretaget en planlagt operation (også hos tandlægen),.
English: The CURE study included 12,562 patients with non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), and presenting within 24 hours of onset of the most recent episode of chest pain or symptoms consistent with ischaemia.
Danish: CURE-undersøgelsen omfattede 12.562 patienter med akut koronarsyndrom uden forhøjelse af STsegmentet (ustabil angina pectoris eller myokardieinfarkt uden forekomst af Q-takker), som indfandt sig inden for 24 timer efter starten på den seneste periode med brystsmerter eller symptomer der svarede til iskæmi.
English: In CAPRIE, in patients treated with either Clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Danish: I CAPRIE var den generelle forekomst af blødninger 9,3 % hos patienter behandlet med enten Clopidogrel eller ASA.
English: In a crossover clinical study, Clopidogrel (300-mg loading dose followed by 75 mg/day) alone and with omeprazole (80 mg at the same time as Clopidogrel) were administered for 5 days.
Danish: Syrepumpehæmmere (PPI): I et klinisk crossover-studie blev Clopidogrel (300 mg mætningsdosis efterfulgt af 75 mg/dag) administreret alene og sammen med omeprazol (80 mg på samme tidspunkt som Clopidogrel) i 5 dage.
English: Experience is limited in patients with moderate hepatic disease who may have bleeding diatheses.
Danish: Der er begrænset erfaring med Clopidogrel til patienter med moderat leversygdom, som kan have blødningstendens.
English: The number of patients experiencing the primary endpoint [cardiovascular (CV) death, myocardial infarction (MI), or stroke] was 582 (9.3%) in the Clopidogrel-treated group and 719 (11.4%) in the placebo-treated group, a 20% relative risk reduction (95% CI of 10%-28%; p = 0.00009) for the Clopidogrel-treated group (17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (PTCA) with or without stent and 10% when they underwent coronary artery bypass graft (CABG).
Danish: Antallet af patienter, som oplevede det primære endpoint [kardiovaskulært dødsfald, myokardieinfarkt eller slagtilfælde] var 582 (9,3 %) i Clopidogrel-gruppen og 719 (11,4 %) i placebogruppen, hvilket giver en relativ risikoreduktion på 20 % (95 % CI: 10 %-28 %; p=0,00009) for Clopidogrelgruppen (en relativ risikoreduktion på 17 %, når patienterne fik konservativ behandling, 29 %, når de fik perkutan transluminal koronar angioplasti (PTCA) med eller uden stent, og 10 %, når de fik koronar bypassoperation (CABG)).
English: Patients were randomised to Clopidogrel (300 mg loading dose followed by 75 mg/day, N = 6,259) or placebo (N = 6,303), both given in combination with ASA (75-325 mg once daily) and other standard therapies.
Danish: Patienterne blev randomiseret til Clopidogrel (300 mg initial stabiliseringsdosis efterfulgt af 75 mg/dag, N=6.259) eller placebo (N=6.303), begge i kombination med ASA (75-325 mg en gang daglig) samt anden standardbehandling.
English: Always take Clopidogrel 1A Pharma exactly as your doctor has told you.
Danish: Tag/brug altid Clopidogrel 1A Pharma nøjagtigt efter lægens anvisninger.
English: EU/1/09/542/001 - 007
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/09/542/001 - 007
English: Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): Clopidogrel treatment should be initiated with a single 300 mg loading dose and then continued at 75 mg once a day (with acetylsalicylic acid (ASA) 75 mg-325 mg daily).
Danish: Hos patienter med akut koronarsyndrom - akut koronarsyndrom uden elevation af ST-segmentet (ustabil angina pectoris eller myokardieinfarkt uden forekomst af Q-takker): Behandling med Clopidogrel bør indledes med en enkelt initial stabiliseringsdosis på 300 mg, hvorefter behandlingen består af 75 mg en gang daglig (sammen med acetylsalicylsyre (ASA) 75 mg-325 mg/dag).
English: • very rare: affects less than 1 user in 10,000
Danish: • meget sjælden: hos færre end 1 bruger ud af 10.000
English: CYP2C19 Phenotype and Genotype Frequency
Danish: Forekomst af CYP2C19 fænotype og genotype Frekvens (%)
English: The number of patients experiencing the co-primary endpoint (CV death, MI, stroke or refractory ischaemia) was 1,035 (16.5%) in the Clopidogrel-treated group and 1,187 (18.8%) in the placebo-treated group, a 14% relative risk reduction (95% CI of 6%-21%, p = 0.0005) for the Clopidogrel-treated group.
Danish: Antallet af patienter, som oplevede det primære endpoint [kardiovaskulært dødsfald, myokardieinfarkt, slagtilfælde eller refraktær iskæmi] var 1.035 (16,5 %) i Clopidogrelgruppen og 1.187 (18,8 %) i placebogruppen, hvilket giver en relativ risikoreduktion på 14 % (95 % CI: 6 %-21 %; p=0,00005) for Clopidogrelgruppen.
English: a planned surgery (including dental) in the next seven days if you have had a clot in an artery of your brain (ischaemic stroke) which occurred within the
Danish: • hvis De har haft en blodprop i en åre (arterie) i hjernen (iskæmisk slagtilfælde), inden for de seneste 7 dage
English: • Pharmacogenetics
Danish: - Farmakogenetik
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 75 mg of Clopidogrel (as besilate).
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver filmovertrukken tablet indeholder 75 mg af Clopidogrel (som besilat).
English: signs of liver problems such as yellowing of the skin and/or the eyes (jaundice), whether or not associated with bleeding which appears under the skin as red pinpoint dots and/or confusion (see section 2 ‘Take special care with Clopidogrel 1A Pharma').
Danish: Dette kan ske på grund af et sjældent fald i visse blodlegemer - tegn på leverproblemer såsom gulning af huden og/eller øjnene (gulsot), uanset om det sker i forbindelse med blødninger, som viser sig under huden som små røde prikker, og/eller forvirring (se afsnit 2 'Vær ekstra forsigtig med at tage Clopidogrel 1A Pharma) - hævelser i munden eller hudproblemer såsom udslæt og kløe, blister på huden.
English: After repeated doses of 75 mg Clopidogrel per day for 10 days in patients with severe hepatic impairment, inhibition of ADP-induced platelet aggregation was similar to that observed in healthy subjects.
Danish: Efter gentagen dosering med Clopidogrel 75 mg daglig i 10 dage svarede den ADP-inducerede trombocytaggregation hos patienter med alvorligt nedsat leverfunktion til den, der blev set hos raske forsøgspersoner.
English: Co-administration of heparin had no effect on the inhibition of platelet aggregation induced by Clopidogrel.
Danish: Samtidig indgift af heparin havde ingen virkning på den hæmning af trombocytaggregationen som Clopidogrel inducerer.
English: • very common: affects more than 1 user in 10
Danish: • meget almindelig; hos mere end 1 ud af 10 brugere
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Danish: Hvis De vil have yderligere oplysninger om {navn}, skal De henvende dig til den lokale repræsentant:
English: Do not take Clopidogrel 1A Pharma:
Danish: Tag ikke Clopidogrel 1A Pharma:
English: • common: affects 1 to 10 users in 100
Danish: • almindelig: hos 1 til 10 brugere ud af 100
English: Patients received Clopidogrel (300 mg loading dose, followed by 75 mg/day, n = 1752) or placebo (n = 1,739), both in combination with ASA (150 to 325 mg as a loading dose, followed by 75 to 162 mg/day), a fibrinolytic agent and, when appropriate,
Danish: Patienterne fik Clopidogrel (300 mg loading dose efterfulgt af 75 mg daglig, n=1.752) eller placebo (n=1.739) begge i kombination med ASA (150-325 mg som loading dose, herefter 75-162 mg dagligt), et fibrinolytisk middel samt heparin, når det var hensigtsmæssigt.
English: Batch
Danish: BATCHNUMMER
English: Published frequencies for the common CYP2C19 phenotypes and genotypes are listed in the table below.
Danish: I tabellen nedenfor ses frekvenserne for de almindelige CYP2C19fænotyper og -genotyper
English: Clopidogrel 1A Pharma 75 mg film-coated tablets Clopidogrel
Danish: Clopidogrel 1A Pharma 75 mg filmovertrukne tabletter Clopidogrel
English: In CLARITY, there was an overall increase in bleeding in the Clopidogrel + ASA group (17.4%) vs. the placebo + ASA group (12.9%).The incidence of major bleeding was similar between groups (1.3% versus 1.1% for the Clopidogrel + ASA and the placebo + ASA groups, respectively).
Danish: I CLARITY var der en generel stigning i antallet af blødninger i clopidrogrel+ASA-gruppen (17,4 %) versus placebo+ASA-gruppen (12,9 %).
English: Therapeutic experience with Clopidogrel is limited in patients with renal impairment.
Danish: Der er begrænset erfaring med behandling af patienter med nyresygdom.
English: Subsequent metabolism of the 2-oxo-Clopidogrel intermediate metabolite results in formation of the active metabolite, a thiol derivative of Clopidogrel.
Danish: Clopidogrel metaboliseres først til en 2-oxo-Clopidogrel-metabolit, der derefter metaboliseres til den aktive metabolit, et tiolderivat af Clopidogrel.
English: • uncommon: affects 1 to 10 users in 1,000
Danish: • ikke almindelig: hos 1 til 10 brugere ud af 1.000
English: • rare: affects 1 to 10 users in 10,000
Danish: • sjælden: hos 1 til 10 brugere end af 10.000
English: NAME OF THE MEDICINAL PRODUCT Clopidogrel 1A Pharma 75 mg film-coated tablets
Danish: LÆGEMIDLETS NAVN Clopidogrel 1A Pharma 75 mg filmovertrukne tabletter
English: Glycoprotein IIb/IIIa inhibitors: Clopidogrel should be used with caution in patients who receive concomitant glycoprotein IIb/IIIa inhibitors (see section 4.4).
Danish: Glykoprotein IIb/IIIa-hæmmere: Clopidogrel skal anvendes med forsigtighed til patienter med øget risiko for blødninger pga. traumer, kirurgi eller andre patologiske tilstande, hvor patienten samtidigt behandles med glykoprotein IIb/IIIa-hæmmere (se pkt.
English: While you are taking Clopidogrel 1A Pharma:
Danish: Mens De er i behandling med Clopidogrel 1A Pharma:
English: Take special care with Clopidogrel 1A Pharma: If any of the situations mentioned below apply to you, you should tell your doctor before taking Clopidogrel 1A Pharma: if you have a risk of bleeding such as a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer) a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, organs or joints of your body)
Danish: • Hvis nogen af følgende situationer gælder for Dem, skal De oplyse det til Deres læge, før De tager Clopidogrel 1A Pharma: Hvis de har risiko for blødninger f.eks. på grund af: - en medicinsk lidelse, der medfører risiko for indre blødninger (såsom et mavesår) - en blødningslidelse, der giver Dem tendens til indre blødning (blødning inde i et af kroppens væv, organer eller led) - en nylig alvorlig kvæstelse - et nyligt kirurgisk indgreb (gælder også tandoperationer) - et planlagt kirurgisk indgreb (gælder også tandoperationer) inden for de næste 7 dage
English: Patients should inform physicians and dentists that they are taking Clopidogrel before any surgery is scheduled and before any new medicinal product is taken.
Danish: Før planlagt kirurgi og før ordination af nye lægemidler bør patienten informere sin læge og tandlæge om, at de tager Clopidogrel.
English: Clopidogrel 1A Pharma 75 mg
Danish: INFORMATION I BRAILLE-SKRIFT Clopidogrel 1A Pharma 75 mg
English: While taking Clopidogrel 1A Pharma, consult your doctor about the breast-feeding of a baby.
Danish: Under behandlingen med Clopidogrel 1A Pharma skal De tale med Deres læge om amning.
English: BEFORE YOU TAKE CLOPIDOGREL 1A PHARMA
Danish: SÅDAN SKAL DE TAGE CLOPIDOGREL 1A PHARMA
English: You have a condition of hardening of arteries (also known as atherosclerosis), and You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease (disturbed blood flow in arms or legs caused by vascular
Danish: De har fået recept på Clopidogrel 1A Pharma til forebyggelse af blodpropper og nedsættelse af risikoen for disse alvorlige hændelser, fordi: - De lider af åreforkalkning (også kaldet aterosklerose) - og - De tidligere har haft et hjerteanfald, slagtilfælde eller en tilstand kaldet perifer arteriel sygdom (kredsløbsforstyrrelser i arme eller ben, forårsaget af vaskulær okklusion), eller - De har haft en alvorlig form for smerter i brystet, som kaldes hjertekrampe (ustabil angina pectoris) eller hjerteanfald (myokardieinfarkt).
English: Clopidogrel received a variety of concomitant medicinal products including diuretics, beta blockers, ACEI, calcium antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents (including insulin), antiepileptic agents, and GPIIb/IIIa antagonists without evidence of clinically significant adverse interactions.
Danish: Imidlertid fik de patienter, som indgik i kliniske forsøg med Clopidogrel, en lang række ledsagende lægemidler såsom diuretika, beta-blokkere, ACE-hæmmere, calciumantagonister, kolesterolsænkende midler, dilatatorer med effekt på koronarkarrene, antidiabetika
English: What Clopidogrel 1A Pharma is and what it is used for Before you take Clopidogrel 1A Pharma
Danish: Det skal De vide, før De begynder at tage Clopidogrel 1A Pharma Sådan skal De tage Clopidogrel 1A Pharma Bivirkninger
English: Since Clopidogrel is metabolised to its active metabolite partly by CYP2C19, use of medicinal products that inhibit the activity of this enzyme would be expected to result in reduced drug levels of the active metabolite of Clopidogrel.
Danish: Anvendelse af lægemidler, der hæmmer aktiviteten af CYP2C19, kan forventes at resultere i nedsat niveau af Clopidogrels aktive metabolit og dermed nedsat klinisk virkning, da Clopidogrel til dels metaboliseres til dets aktive metabolit af CYP2C19.
English: Excipients
Danish: Hjælpestoffer
English: Frequency (%)
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE)
English: Extensive metabolism: CYP2C19*1/*1 Intermediate metabolism:
Danish: CYP2C19*1/*1
English: Common
Danish: ANDET
English: It is used in patients from 12 years of age and weighing at least 40 kg.
Danish: Det anvendes hos patienter, der over 12 år og vejer mindst 40 kg.
English: This summary was last updated in August-2014.
Danish: Dette sammendrag blev senest ajourført i 08-2014.
English: Data from this study collected until week 96 showed that this effect was maintained over time.
Danish: Resultaterne indtil uge 96 af denne undersøgelse viste, at denne virkning holdt sig med tiden.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Triumeq on 1 September 2014.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Triumeq den 1. september 2014.
English: This is a summary of the European public assessment report (EPAR) for Triumeq.
Danish: Dette er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Triumeq.
English: The full EPAR and risk management plan summary for Triumeq can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR og resuméet af risikostyringsplanen for Triumeq findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Data from this study had already been used in the authorisation of Tivicay.
Danish: Resultaterne fra denne undersøgelse er i forvejen blevet anvendt ved godkendelsen af Tivicay.
English: After 48 weeks, 88% of the patients given the combination found in Triumeq (364 out of 414) responded to treatment, compared with 81% of the patients who were given Atripla (338 out of 419).
Danish: Efter 48 uger virkede behandlingen hos 88 % af de patienter, der fik kombinationen i Triumeq (364 ud af 414), sammenholdt med 81 % af dem, der fik Atripla (338 ud af 419).
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Triumeq's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) afgjorde, at fordelene ved Triumeq overstiger risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: The CHMP concluded that the medicine had demonstrated its effectiveness in previously untreated patients, and that similar benefits are expected in patients who have received previous treatment.
Danish: CHMP konkluderede, at lægemidlet havde vist sin effektivitet hos tidligere ubehandlede patienter, og at det forventes at have tilsvarende fordele hos tidligere behandlede patienter.
English: A risk management plan has been developed to ensure that Triumeq is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at Triumeq anvendes så sikkert som muligt.
English: Other information about Triumeq
Danish: Andre oplysninger om Triumeq
English: Before starting treatment with Triumeq, all patients should have a test to find out if they have a gene called ‘HLA-B (type 5701)'.
Danish: Før påbegyndelse af behandlingen med Triumeq bør alle patienter testes for at finde ud af, om de har genet “HLA-B (type 5701)”.
English: The combination of abacavir and lamivudine has been authorised as Kivexa since 2004.
Danish: Kombinationen af abacavir og lamivudin har været godkendt under navnet Kivexa siden 2004.
English: Triumeq dolutegravir / abacavir / lamivudine
Danish: Triumeq dolutegravir / abacavir / lamivudin
English: In patients taking some of the components of Triumeq, certain serious side effects have been seen including hypersensitivity (allergic).
Danish: Hos patienter, der tager visse af bestanddelene i Triumeq, er der set visse alvorlige bivirkninger, herunder overfølsomhed (allergi).
English: The main measure of effectiveness was the response rate, which was the proportion of patients with a reduction of the levels of virus in the blood (viral load) to fewer than 50 copies of HIV RNA per ml.
Danish: I undersøgelserne blev effektiviteten hovedsagelig bedømt på andelen med respons, dvs. den andel af patienterne, der fik reduceret virusindholdet i blodet til færre end 50 kopier hiv-RNA pr. milliliter.
English: Triumeq does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Danish: Triumeq helbreder ikke hiv-infektion eller aids, men kan sinke den skade på immunsystemet og de infektioner og sygdomme, der er forbundet med aids.
English: Patients with this gene are at an increased risk of having an allergic reaction to abacavir, so they should not take Triumeq.
Danish: Patienter med dette gen har øget risiko for overfølsomhed over for abacavir og skal derfor ikke have Triumeq.
English: Results from this study showed that Triumeq was absorbed into the body in the same way as the separate medicines.
Danish: Undersøgelsen viste, at Triumeq blev optaget i kroppen på samme måde som fra de separate lægemidler.
English: The most common side effects with Triumeq (which may affect more than 1 in 10 people) are insomnia (difficulty sleeping), headache, nausea (feeling sick), diarrhoea and fatigue (tiredness).
Danish: De almindeligste bivirkninger med Triumeq (som kan forekomme hos mere end 1 ud af hver 10 behandlede) er søvnløshed, hovedpine, kvalme, diarré og træthed.
English: The combination of dolutegravir, abacavir and lamivudine (as found in Triumeq) was evaluated in one main study involving 833 previously untreated patients.
Danish: Kombinationen dolutegravir, abacavir og lamivudin (svarende til Triumeq) blev vurderet i én hovedundersøgelse med 833 tidligere ubehandlede patienter.
English: What measures are being taken to ensure the safe and effective use of Triumeq?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Triumeq?
English: Giving the combined medicine rather than the single medicines reduces the number of tablets patients have to take, helping them to adhere to their treatment.
Danish: Når det kombinerede lægemiddel bruges i stedet for hvert lægemiddel for sig, behøver patienterne ikke tage så mange tabletter og har derved lettere ved at overholde behandlingen.
English: What is Triumeq and what is it used for?
Danish: Hvad er Triumeq, og hvad anvendes det til?
English: All three active substances in Triumeq are already available in the European Union (EU) as singlecomponent medicines: abacavir has been authorised as Ziagen since 1999, lamivudine as Epivir since 1996, and dolutegravir as Tivicay since January 2014.
Danish: Alle tre aktive stoffer i Triumeq fås allerede i EU som lægemidler indeholdende et enkelt aktivt stof: Abacavir har været godkendt under navnet Ziagen siden 1999, lamivudin under navnet Epivir siden 1996, og dolutegravir under navnet Tivicay siden januar 2014.
English: It is not intended to provide practical advice on how to use Triumeq.
Danish: Det er ikke en praktisk vejledning i, hvordan Triumeq skal anvendes.
English: They both work in similar ways by blocking the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses.
Danish: De virker begge ved at blokere enzymet reverse transcriptase, der produceres af hiv og gør det muligt for virusset at inficere celler og producere flere virus.
English: Why is Triumeq approved?
Danish: Hvorfor blev Triumeq godkendt?